Research

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

Thursday, January 21, 2021 - 10:12pm

The FDA approval of Cabenuva underscores the value of community-centric research and I am pleased this new option will be available for those living with HIV.

Key Points: 
  • The FDA approval of Cabenuva underscores the value of community-centric research and I am pleased this new option will be available for those living with HIV.
  • ViiV Healthcare will begin shipping Cabenuva to wholesalers and specialty distributors in the US in February 2021.
  • Because Cabenuva is a complete regimen, coadministration with other antiretroviral medications for the treatment of HIV-1 infection is not recommended.
  • ViiV Healthcare is committed to providing assistance to eligible people living with HIV in the US who need our medicines.

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

Thursday, January 21, 2021 - 9:44pm

The FDA approval of Cabenuva underscores the value of community-centric research and I am pleased this new option will be available for those living with HIV.

Key Points: 
  • The FDA approval of Cabenuva underscores the value of community-centric research and I am pleased this new option will be available for those living with HIV.
  • ViiV Healthcare will begin shipping Cabenuva to wholesalers and specialty distributors in the US in February 2021.
  • Because Cabenuva is a complete regimen, coadministration with other antiretroviral medications for the treatment of HIV-1 infection is not recommended.
  • ViiV Healthcare is committed to providing assistance to eligible people living with HIV in the US who need our medicines.

Global Dry Eye Syndrome Drugs Market Research 2021-2025 | Industry Impact Analysis | Technavio

Thursday, January 21, 2021 - 8:28pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210121005893/en/
    Technavio has announced its latest market research report titled Global Dry Eye Syndrome Drugs Market 2021-2025 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your business?
  • The report on the dry eye syndrome drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The dry eye syndrome drugs market analysis includes the product and geography landscape.
  • This study identifies the changing lifestyle and rising cases of diseases contributing to dry eye syndrome as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years.

SoftwareReviews Announces Enterprise Search Data Quadrant Award Winners

Thursday, January 21, 2021 - 6:00pm

TORONTO, Jan. 21, 2021 /PRNewswire-PRWeb/ -- SoftwareReviews , a division of world-class IT research and consulting firm Info-Tech Research Group , has published its 2021 Enterprise Search Data Quadrant Awards, naming three vendors as Gold Medalists.

Key Points: 
  • TORONTO, Jan. 21, 2021 /PRNewswire-PRWeb/ -- SoftwareReviews , a division of world-class IT research and consulting firm Info-Tech Research Group , has published its 2021 Enterprise Search Data Quadrant Awards, naming three vendors as Gold Medalists.
  • Vendors were rated on their product features, vendor capabilities, and the relationship with their software partner:
    What makes the SoftwareReviews Data Quadrant different?
  • "Enterprise Search is the only way to effectively find the required data in massive data lakes and lakehouses.
  • About SoftwareReviews Data Quadrant Awards and Software Reports:
    SoftwareReviews Data Quadrant Awards recognize outstanding vendors in the technology marketplace as evaluated by their users annually.

INW: Innovations in Nutrition + Wellness Implements Industry-Leading Cloud Financial Planning and Analysis Solution, OneStream XF

Thursday, January 21, 2021 - 6:00pm

OneStream software was named a Leader in the latest Gartner Magic Quadrant for Cloud Financial Planning and Analysis Solutions.

Key Points: 
  • OneStream software was named a Leader in the latest Gartner Magic Quadrant for Cloud Financial Planning and Analysis Solutions.
  • OneStream XF, a unified platform that simplifies financial consolidation, planning, reporting and analytics consolidated INW's various financial systems giving the company a singular tool that was fully in use in just 60 days.
  • OneStream XF provides internal stakeholders a more efficient, agile, and comprehensive financial picture.
  • Sources: Gartner Magic Quadrant for Cloud Financial Planning and Analysis Solutions, Robert Anderson, John Van Decker and Greg Leiter, 06 October 2020.

SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS

Thursday, January 21, 2021 - 5:00pm

Blaze enables the direct coupling of imaged cIEF charge variant analysis with high-resolution mass spectrometry to detect intact proteins.

Key Points: 
  • Blaze enables the direct coupling of imaged cIEF charge variant analysis with high-resolution mass spectrometry to detect intact proteins.
  • Imaged cIEF-MS technology provides a groundbreaking solution for those looking for better and faster tools to characterize their increasingly complex biomolecules.
  • The Blaze System coupled to high-resolution mass spectrometry provides a streamlined approach that can reduce lengthy sample prep and deliver increased sample throughput.
  • SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all.

New Deep Learning Discovery Paves Way for AI Interpretation of Brainwave Data

Thursday, January 21, 2021 - 4:00pm

Machine learning has the potential to relieve some of this burden, but EEG data is extremely multidimensional and can be expensive, and time-consuming to annotate.

Key Points: 
  • Machine learning has the potential to relieve some of this burden, but EEG data is extremely multidimensional and can be expensive, and time-consuming to annotate.
  • This means there are typically not enough labelled examples for supervised deep neural networks to learn from in order to create an efficient AI.
  • While labelled-EEGs identifying sleep stages and brain activity are scarce, there is ample unlabeled data that exists.
  • Banville found that when limited numbers of labelled data were available, his self-supervised learning approach outperformed traditional supervised learning methods that rely purely on labelled data.

Reliatrace, Inc. Announces Patent for Self-Regulating Flexible Heating Device

Thursday, January 21, 2021 - 3:33pm

10,856,365 for a Self-Regulating Flexible Heating Device.

Key Points: 
  • 10,856,365 for a Self-Regulating Flexible Heating Device.
  • With this technology, the risk of overheating is greatly reduced compared with alternative heating methods using thermostats or other temperature controls.
  • This Self-Regulating Flexible Heating Device has already been used in the beauty industry.
  • While Reliatrace primarily works with B2B clients, earlier this year the company launched its first direct-to-consumer product using its patented Self-Regulating Flexible Heating Device in a new tool for bakers.

AltaSea & Flying Lion Launch Scientific and Educational Partnership to Develop an “Unmanned Aircraft System Center of Excellence”

Thursday, January 21, 2021 - 3:30pm

FLI, which started its partnership on January 15, joins two organizations with aligning missions to accelerate scientific collaboration and transform the rapidly-growing Blue Economy at AltaSea.

Key Points: 
  • FLI, which started its partnership on January 15, joins two organizations with aligning missions to accelerate scientific collaboration and transform the rapidly-growing Blue Economy at AltaSea.
  • "Flying Lion will be an important addition to our campus as we continue our leadership in the Blue Economy, said AltaSea CEO Tim McOsker.
  • The synergy between AltaSeas campus and Flying Lion UAS expertise creates an optimal environment to jointly develop breakthrough ocean-related research and discovery solutions to environmental problems, said Flying Lion CEO Barry Brennan.
  • Were pleased to welcome Flying Lion and its Unmanned Aircraft System (UAS) Center of Excellence to AltaSea at the Port of Los Angeles.

Meissa Announces First Dosing in Phase 2 Study of Intranasal Live Attenuated Vaccine Candidate for RSV

Thursday, January 21, 2021 - 2:00pm

Meissa Vaccines (Meissa), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that the first adult participants have been dosed in a Phase 2 study of MV-012-968, the companys intranasal live attenuated vaccine candidate against respiratory syncytial virus (RSV).

Key Points: 
  • Meissa Vaccines (Meissa), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that the first adult participants have been dosed in a Phase 2 study of MV-012-968, the companys intranasal live attenuated vaccine candidate against respiratory syncytial virus (RSV).
  • Meissa is developing MV-012-968, an intranasal (needle-free), live attenuated vaccine candidate, to protect infants and at-risk, older adults from RSV.
  • Meissa plans to initiate a Phase 1c study in sero-negative infants in the first half of this year.
  • Meissa is advancing live attenuated vaccine candidates against life threatening respiratory viruses, including respiratory syncytial virus (RSV), SARS-CoV-2 (COVID-19), and human metapneumovirus (hMPV).